Please complete the CAPTCHA to continue
@aeovian.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Davis Ryman, Md Phd is listed as Chief Medical Officer at Aeovian Pharmaceuticals at Aeovian Pharmaceuticals, based in Greater Chicago Area, United States, United States. AeroLeads shows a work email signal at aeovian.com and a matched LinkedIn profile for Davis Ryman, Md Phd.
Davis Ryman, Md Phd previously worked as Chief Medical Officer at Aeovian Pharmaceuticals and Chief Medical Officer at Levo Therapeutics. Davis Ryman, Md Phd holds Doctor Of Medicine (M.D.), Nih Medical Scientist Training Program (Mstp) from Case Western Reserve University School Of Medicine.
This section adds company-level context without repeating Davis Ryman, Md Phd's masked contact details.
AeroLeads found 1 current-domain work email signal for Davis Ryman, Md Phd. Compare company email patterns before reaching out.
• Board-certified neurologist and geneticist with over 10 years of combined experience in the pharmaceutical and biotechnology industries and academic clinical and translational research in neurological and genetic disorders• Recent experience in clinical development of AAV9 gene therapies for neurologic disorders, including work on two global Phase 3 trials, successful Sakigake application (Japanese breakthrough therapy designation), and BLA and MAA applications, leading to 2019 FDA approval of ZOLGENSMA for spinal muscular atrophy• Prior experience in design and execution of eight Phase 1-3B clinical trials in Alzheimer's disease, Parkinson's disease, and rare/orphan neurologic disorders, including progressive supranuclear palsy (PSP), early-onset autosomal dominant Alzheimer’s disease (ADAD), and advanced Parkinson’s disease• Other accomplishments include clinical leadership of two programs through FDA Pre-IND briefing books and successful IND applications, two successful Orphan Drug Designation (ODD) applications, completion and management approval of Phase 1-3 clinical development plans for three assets in neurological indications, and pre and post-approval work on DUOPA™, a drug-device combination product which earned FDA approval and orphan drug designation in 2015 and Japanese approval in 2016 for treatment of advanced Parkinson’s disease
Listed skills include Clinical Trials, Neuroscience, Neurology, Clinical Research, and 23 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Berkeley, California, US
Aeovian Pharmaceuticals is a biopharmaceutical company aiming to discover, develop and commercialize innovative therapeutics for the treatment of rare and age-related diseases, with lead compounds including several novel and highly selective small molecules that potently inhibit the mTORC1 pathway.
Skokie, IL, US
Led clinical development of intranasal carbetocin (LV-101) and other pipeline programs for the treatment of Prader-Willi syndrome (PWS), through the 2022 acquisition of Levo Therapeutics
Clinical development of AAV gene therapy treatments for rare and serious genetic neurological disorders, including spinal muscular atrophy, Rett syndrome, and amyotrophic lateral sclerosis (ALS) due to SOD1 mutations (through $8.7B acquisition by Novartis)
North Chicago, Illinois, US
Cleveland, Ohio, US
Franklin Lakes, New Jersey, US
San Jose, California, US
Berkeley, CA, US
Quick answers generated from the profile data available on this page.
Davis Ryman, Md Phd works for Aeovian Pharmaceuticals.
Davis Ryman, Md Phd is listed as Chief Medical Officer at Aeovian Pharmaceuticals at Aeovian Pharmaceuticals.
AeroLeads has found 1 work email signal at @aeovian.com for Davis Ryman, Md Phd at Aeovian Pharmaceuticals.
Davis Ryman, Md Phd is based in Greater Chicago Area, United States, United States while working with Aeovian Pharmaceuticals.
Davis Ryman, Md Phd has worked for Aeovian Pharmaceuticals, Levo Therapeutics, Avexis, Inc., Abbvie, and Dominantly Inherited Alzheimer Network Trials Unit (Dian-Tu).
You can use AeroLeads to view verified contact signals for Davis Ryman, Md Phd at Aeovian Pharmaceuticals, including work email, phone, and LinkedIn data when available.
Davis Ryman, Md Phd holds Doctor Of Medicine (M.D.), Nih Medical Scientist Training Program (Mstp) from Case Western Reserve University School Of Medicine.
Davis Ryman, Md Phd is listed with skills including Clinical Trials, Neuroscience, Neurology, Clinical Research, Drug Development, Bioinformatics, Medicine, and Clinical Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts